Philips MRI Scanner to be Used in Prestigious 6 Year Project

Royal Philips ElectronicsScientists from Guys' and St Thomas', King's College, London, Imperial College, London and University of Oxford will use a Philips state-of-the-art MRI scanner combined with specially developed imaging techniques to investigate the wombs of pregnant women and image their babies' brains, even while the fetuses are moving.

To deliver this ambitious project new MRI facilities have been installed at St Thomas' Hospital, creating a dedicated imaging suite, integrated with the neonatal critical care unit and a wide bore scanner for fetal imaging. Philips Healthcare has supplied an Achieva TX MRI system and an Avalon fetal monitor, and will be providing ongoing support to ensure the systems consistently provide peak performance.

The researchers will use the advanced imaging techniques to map how the human brain grows and forms connections, with the aim of mapping out for the first time how the brain assembles itself, and also observe how brain connections and patterns of activity, seen on older subjects, emerge as babies grow in the womb and just after birth. Up to 1,500 subjects will be studied to examine both normal development and also explore early signs of disabilities such as autism and attention deficit disorders. The objective is to create a "connectome", a kind of wiring diagram of the fetal and infant brain showing the formation of brain structures such as the cerebral cortex, where 'thinking' occurs, or the hippocampus, which is central to memory, and the connections between them.

Professor David Edwards, director of the Centre for the Developing Brain at King's said "We want to create a series of atlases showing the human brain at different stages in development. Eventually, we hope to have enough data to compare the brains of children who go on to develop normally with those who develop conditions like autism and attention deficit disorders, so that we can see if such conditions have their origins in the way the brain developed in the womb."

MRI is already used to image brains of unborn babies, often after ultrasound exams have shown potential abnormalities, and it is also increasingly used to help in the management of premature babies and other vulnerable infants. The information provided is becoming more and more important as new treatments are developed that can improve the outcome for babies at risk of long-term brain damage occurring around the time of birth. However, while established imaging techniques provide detailed anatomical information and reveal if there is structural brain damage, mapping of brain connectivity and emerging brain function is a task at the limits of current capabilities. The team will, therefore, have to develop both advanced imaging methods and new ways to analyze the images to extract the vital connectome information.

Jo Hajnal, professor of imaging science at King's, a physicist who specializes in imaging subjects who cannot remain still while they are scanned said "We will scan about 1,500 children; about 500 will be fetuses, another 500 will be new-born normal babies, and the rest will be at-risk babies, including 200 premature babies and about 300 babies identified as being at higher risk of development autism."

Professor Hajnal goes on "The fetal scans let us look back into the womb and see how the brain assembles itself, while the normal babies will give us a sense of just what a brain looks like, and how it works when a person enters the world. We can compare these images with what we see in the brains of at-risk babies and maybe find out what makes them different."

Once the images have been collected, advanced computational analysis methods will be developed and applied to extract connectome information. This critical part of the project will be led by Professor Daniel Rueckert, Department of Computing, Imperial College London, and Professor Steve Smith of Oxford University's centre for Functional MRI of the Brain.

About Royal Philips Electronics
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

AI can Open Up Beds in the ICU

At the height of the COVID-19 pandemic, hospitals frequently ran short of beds in intensive care units. But even earlier, ICUs faced challenges in keeping beds available. With an aging...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI Model Predicting Two-Year Risk of Com…

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New Research Explores How AI can Build T…

In today’s economy, many workers have transitioned from manual labor toward knowledge work, a move driven primarily by technological advances, and workers in this domain face challenges around managing non-routine...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...